At Virupaksha, delivering excellence in pharmaceutical manufacturing is not just a goal; it’s an unwavering commitment to quality and innovation. Renowned for producing high-purity Fluconazole, our facilities are meticulously crafted to meet the stringent standards set by WHO-GMP, ensuring that every batch reflects our dedication to global health. Our adherence to ISO 9001 guarantees that we maintain a robust quality management system, while ISO 14001 highlights our commitment to environmentally sustainable practices throughout the production process.
This meticulous attention to detail is particularly crucial given Fluconazole’s vital role in treating cryptococcal meningitis—a life-threatening condition affecting immunocompromised patients worldwide. With each step of our manufacturing process steeped in scientific rigor and ethical responsibility, Virupaksha stands at the forefront of pharmaceutical excellence, dedicated to making a profound impact on patient care globally.
Other Latest News
- Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market June 24, 2026 12:30 pm EIN Presswire AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors, a category of drugs that work by blocking cancer cells…
- Insilico Medicine and SK Biopharmaceuticals Forge $2.5 Billion AI-Driven Collaboration to Accelerate Neuroimmune Disorder Drug Discovery June 23, 2026 8:38 am Bioengineer.org In a groundbreaking advancement for pharmaceutical innovation, Insilico Medicine and SK Biopharmaceuticals have announced an ambitious AI-powered collaboration targeting neuroimmune disorders within the central nervous system (CNS). This partnership, …
- Next-Generation DNA Repair Therapies Open New Frontiers in Oncology June 22, 2026 12:30 pm EIN Presswire AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability …
- IoT In Logistics Market Register Growth of 13.2% CAGR To Reach USD 130.5 billion by 2035: Market Research Future June 22, 2026 10:44 am EIN Presswire Healthcare and pharmaceutical logistics are expanding at a CAGR of 14.6%, fueled by serialization mandates and vaccine distribution chain requirements. NY, CA, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- The global IoT In Logistics Market …
- <![CDATA[FAQ: Strait of Hormuz Reopening — What It Means for Pharma Supply Chains]]> June 16, 2026 5:32 pm Pharmaceutical Commerce After more than three months of closure that exposed vulnerabilities in global pharmaceutical supply chains, the Strait of Hormuz could reopen following a US-Iran framework agreement announced June 15. What does that mean for drug supply, freight, and long …
- Sensex today | Stock Market Highlights: Sensex, Nifty surge nearly 2% as falling oil prices lift market sentiment June 12, 2026 5:53 pm The Hindu Business Line Sensex Today, Nifty 50 | Stock Market Highlights - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 12th June 2026 Sensex closed 1,695 points higher at 75,527, while the Nifty gained 461 points to …
- Sensex today | Stock Market Highlights: Sensex, Nifty end flat as early gains fade; gold prices slide sharply June 10, 2026 12:26 pm The Hindu Business Line A blue-toned stock image showing coin stacks, a bar-style chart, and a rising line to convey financial growth, market trends, and investment analysis in a professional business context. istockphoto for BL Sensex Today, Nifty 50 | Stock Market Live Updates …
- Dangerous waters: Geopolitics, supply chains and access to medicines June 10, 2026 10:16 am Pharmaceutical Technology Shortages of medicines for conditions such as diabetes, attention deficit hyperactivity disorder (ADHD) and hormone replacement therapy (HRT) have long been a feature of the healthcare landscape, but recent events have thrown the issue into starker relief …
- India News | Shortage of Cisplatin and Carboplatin is Threat to Cancer Patients, Alerts Top Experts June 8, 2026 3:08 pm Latestly By Shalini Bhardwaj New Delhi [India], June 8 (ANI): The shortage of platinum-based cancer drugs like Cisplatin and Carboplatin is a threat to cancer care treatment, the top Experts from AIIMS Delhi stated, as these drugs play a crucial role in the …
- New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research Hospitals Can Seize the Moment June 3, 2026 3:27 pm MedCity News We continue to see enormous technological and scientific progress in the area of drug discovery, with the promise of AI to upend traditional models and approaches becoming more fully realized by the day. However, there persists a glaring disconnect between …
- Top 10 U.S. Biopharma Clusters 2026 June 1, 2026 7:37 pm Genetic Engineering & Biotechnology News -New York Some of the forces that shape biopharma cluster development are constants year after year, such as the emergence of startups from university and research institute labs to develop new treatments, thanks to ideas backed by the brains of researchers and …
- D-Wave Quantum Still Lags Behind The Industry Average, But Pessimism Is Somewhat Bloviated Post Q1 2026 Revenue Drop May 31, 2026 8:35 am Seeking Alpha D-Wave Quantum Inc. underperforms peers on return and volatility metrics and remains more unpredictable than other pure-play quantum companies, but investor pessimism is exaggerated. Recent revenue declines were expected due to prior one-time sales; …
- In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides May 27, 2026 7:46 pm Investing News Network SHELTON, CT / ACCESS Newswire / May 26, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, compares potential treatment options for Ebola …
- China’s State Support and Pricing Practices in the Biotechnology Sector May 27, 2026 6:27 pm The Foundation for Defense of Democracies (FDD) Introduction Commission Secretary Barton and distinguished members of the Commission, on behalf of the Foundation for Defense of Democracies, thank you for the opportunity to testify before you today. This hearing is timely. China’s biotechnology sector …
- Business News | Morepen Labs Q4 Net Profit Rises 69 Percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 Percent for FY 2025-26 May 27, 2026 6:43 am Latestly NewsVoir Gurugram (Haryana) [India], May 27: Morepen Laboratories Limited reported strong Q4 FY26 performance with net profit rising 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. Revenue growth during the quarter was …
- <![CDATA[How Digital Strategies Transform Pharma Supply Chains in 2026]]> May 27, 2026 6:25 am Pharmaceutical Commerce The pharmaceutical supply chain is a complex, regulated ecosystem that orchestrates the strategic and operative exchange of information, products, and capital among suppliers, manufacturers, coordination providers, customers, and regulators. Its growing …
- Analytical Champions: Tao Chen May 22, 2026 1:37 pm The Medicine Maker Tao Chen is part of a new generation of pharmaceutical analytical scientists helping to reshape how drugs are developed and understood. At Genentech, her work sits at the intersection of analytical chemistry and emerging therapeutic modalities, where …
- Investornewsbreaks Nanoviricides (NYSE American: NNVC) Closes $2 Million Registered Direct Offering May 20, 2026 8:09 am MENAFN (MENAFN- Investor Brand Network) NanoViricides, Inc. (NYSE American: NNVC) announced the closing of its previously announced registered direct offering with a single institutional investor, consisting of 1,333,334 shares of common stock, or pre-funded …
- Gland Pharma, Sun Pharmaceutical, Laurus Labs shares zoom up to 16% to hit 52-week highs; here's why May 18, 2026 8:21 am Business Today Shares of pharmaceutical companies such as Gland Pharma Ltd, Sun Pharmaceutical Industries Ltd and Laurus Labs Ltd touched their respective one-year high levels in Monday's trade even as domestic benchmarks were trading lower. Gland Pharma jumped 15.85 …
- This week in AI research: Fields medalist says GPT-5.5 Pro did PhD-level math in an hour, Anthropic teaches Claude to ‘dream’ May 13, 2026 8:39 pm R&D Magazine The past week or so, Anthropic’s gated Mythos model remains a news fixture, drawing White House policy attention, a Mozilla proof point and a somewhat skeptical review from an open-source project. Earlier this month, OpenAI had formalized a split between …
- <![CDATA[Pharmaceutical Executive Daily: Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Agreement]]> May 8, 2026 7:51 pm Pharmaceutical Executive Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, Angelini Pharma announces a $4.1 billion agreement to acquire Catalyst …
- Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing May 7, 2026 4:56 pm Pharmaceutical Technology Eli Lilly has shared plans to invest a further $4.5bn into its manufacturing presence in Indiana, taking the pharma company’s total investment into the state to $21bn since 2020. Through this commitment, Lilly will expand operations across two of the …
- SGS launches GMP-compliant NMR testing for Chinese pharma industry May 7, 2026 6:36 am Biospectrum Asia SGS launches GMP-compliant NMR testing for Chinese pharma industry May 7, 2026 | Thursday | News NMR delivers high-resolution structural clarity and quantitative precision SGS, world’s leading Testing, Inspection and Certification company, has expanded its …
- Building quality into drug development for safer, faster medicines April 29, 2026 10:54 am Medical News In this interview, News Medical-Life Sciences speaks with Anil Kane, pharmaceutical development expert at Thermo Fisher Scientific’s Pharma Services Group, about how quality is built into Drug Development from early design through manufacturing. He …
- Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 April 29, 2026 3:40 am Business Upturn MUMBAI, India, April 28, 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) …
- <![CDATA[Pharmaceutical Executive Daily: FDA Approves Breztri]]> April 29, 2026 3:29 am Pharmaceutical Executive Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, a pharma M&A roundup covers two significant deals, Sun Pharma's $11 …
- North Korean Hackers Target Pharma Firms with Malware-Laced Excel Attacks April 27, 2026 11:50 pm GBHackers North Korean state-backed hackers are using weaponized Excel-themed files to infect pharmaceutical and life science companies with malware, abusing Windows shortcut files, PowerShell, and cloud storage for stealthy data theft. The campaign begins with …
- Vistin Reports First Quarter 2026 Results April 24, 2026 6:47 pm RTTNews Vistin Pharma ASA (VISTN), a pharmaceutical manufacturing company, announced on Friday financial results for the first quarter of 2026. Vistin produces an estimated 10% of the world's metformin hydrochloride, an essential medication in the treatment …
- Business News | Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time April 20, 2026 7:00 am Latestly NewsVoir Gurugram (Haryana) [India], April 20: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, …
- Business News | Rusan Pharma Achieves Global GMP Milestone with PMDA Japan Approval April 20, 2026 6:59 am Latestly VMPL Mumbai (Maharashtra) [India], April 20: Rusan Pharma, a leading pharmaceutical company pioneering pain management, movement disorder, and addiction solutions worldwide, has achieved a significant global regulatory milestone with the successful Good …